Platform Therapeutics files Form D for $4 million equity offering
The Andover, Massachusetts biotech reported $1.75 million raised from one investor as of a August 12, 2026 first sale date.
SEC filing
1 story
The Andover, Massachusetts biotech reported $1.75 million raised from one investor as of a August 12, 2026 first sale date.
SEC filing